Reversal of mydriasis by dapiprazole

Ann Ophthalmol. 1990 Apr;22(4):131-3, 138.

Abstract

The effect of topical dapiprazole, an alpha-adrenergic receptor blocker, in reversing mydriasis was studied in 50 subjects who received tropicamide 1% and phenylephrine 2.5%. There was a significant difference in the decrease in pupil size between the eye that received dapiprazole and the control eye. This study suggests that dapiprazole 0.5% eye drops are effective and safe in reversing mydriasis after instillation of tropicamide 1% and phenylephrine 2.5%.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adrenergic alpha-Antagonists / pharmacology*
  • Adult
  • Aged
  • Blood Pressure / drug effects
  • Female
  • Heart Rate / drug effects
  • Humans
  • Intraocular Pressure / drug effects
  • Male
  • Middle Aged
  • Phenylephrine / antagonists & inhibitors*
  • Piperazines
  • Pupil / drug effects*
  • Pyridines / antagonists & inhibitors*
  • Triazoles / pharmacology*
  • Tropicamide / antagonists & inhibitors*
  • Visual Acuity / drug effects

Substances

  • Adrenergic alpha-Antagonists
  • Piperazines
  • Pyridines
  • Triazoles
  • Phenylephrine
  • dapiprazole
  • Tropicamide